These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

856 related items for PubMed ID: 16701139

  • 1. Allergy diagnosis, allergen repertoires, and their implications for allergen-specific immunotherapy.
    Crameri R.
    Immunol Allergy Clin North Am; 2006 May; 26(2):179-89, v. PubMed ID: 16701139
    [Abstract] [Full Text] [Related]

  • 2. Recombinant allergens for diagnosis and therapy of allergic disease.
    Chapman MD, Smith AM, Vailes LD, Arruda LK, Dhanaraj V, Pomés A.
    J Allergy Clin Immunol; 2000 Sep; 106(3):409-18. PubMed ID: 10984358
    [Abstract] [Full Text] [Related]

  • 3. Recombinant allergens for immunotherapy.
    Chapman MD, Smith AM, Vailes LD, Pomés A.
    Allergy Asthma Proc; 2002 Sep; 23(1):5-8. PubMed ID: 11894735
    [Abstract] [Full Text] [Related]

  • 4. Developments in allergen-specific immunotherapy: from allergen extracts to allergy vaccines bypassing allergen-specific immunoglobulin E and T cell reactivity.
    Focke M, Swoboda I, Marth K, Valenta R.
    Clin Exp Allergy; 2010 Mar; 40(3):385-97. PubMed ID: 20210812
    [Abstract] [Full Text] [Related]

  • 5. From allergen genes to new forms of allergy diagnosis and treatment.
    Vrtala S.
    Allergy; 2008 Mar; 63(3):299-309. PubMed ID: 18269675
    [Abstract] [Full Text] [Related]

  • 6. Recombinant allergens for immunotherapy.
    Valenta R, Niederberger V.
    J Allergy Clin Immunol; 2007 Apr; 119(4):826-30. PubMed ID: 17335886
    [Abstract] [Full Text] [Related]

  • 7. [Interests of recombinant allergens in the practice of allergy].
    Karoui O, Leimgruber A, Spertini F.
    Rev Med Suisse; 2013 Jan 09; 9(368):22-7. PubMed ID: 23367699
    [Abstract] [Full Text] [Related]

  • 8. Standardization of allergen-specific immunotherapy vaccines.
    Spangfort MD, Larsen JN.
    Immunol Allergy Clin North Am; 2006 May 09; 26(2):191-206, v-vi. PubMed ID: 16701140
    [Abstract] [Full Text] [Related]

  • 9. [Diagnostic and therapeutic value of synthetic or recombinant allergens].
    Spertini F.
    Rev Med Suisse Romande; 1999 Mar 09; 119(3):235-9. PubMed ID: 10218421
    [Abstract] [Full Text] [Related]

  • 10. Genetic allergen modification in the development of novel approaches to specific immunotherapy.
    Mutschlechner S, Deifl S, Bohle B.
    Clin Exp Allergy; 2009 Nov 09; 39(11):1635-42. PubMed ID: 19624521
    [Abstract] [Full Text] [Related]

  • 11. Allergen-related approaches to immunotherapy.
    Rolland JM, Gardner LM, O'Hehir RE.
    Pharmacol Ther; 2009 Mar 09; 121(3):273-84. PubMed ID: 19111571
    [Abstract] [Full Text] [Related]

  • 12. [New approaches for allergen-specific immunotherapy].
    Cantillo JF, Puerta L.
    Biomedica; 2010 Mar 09; 30(3):440-53. PubMed ID: 21713346
    [Abstract] [Full Text] [Related]

  • 13. Genetically engineered hybrid proteins from Parietaria judaica pollen for allergen-specific immunotherapy.
    González-Rioja R, Ibarrola I, Arilla MC, Ferrer A, Mir A, Andreu C, Martínez A, Asturias JA.
    J Allergy Clin Immunol; 2007 Sep 09; 120(3):602-9. PubMed ID: 17561242
    [Abstract] [Full Text] [Related]

  • 14. Novel ways for immune intervention in immunotherapy: mucosal allergy vaccines.
    Mascarell L, Van Overtvelt L, Moingeon P.
    Immunol Allergy Clin North Am; 2006 May 09; 26(2):283-306, vii-viii. PubMed ID: 16701145
    [Abstract] [Full Text] [Related]

  • 15. Genetically engineered and synthetic allergen derivatives: candidates for vaccination against type I allergy.
    Valenta R, Vrtala S, Focke-Tejkl M, Bugajska-Schretter, Ball T, Twardosz A, Spitzauer S, Grönlund H, Kraft D.
    Biol Chem; 1999 May 09; 380(7-8):815-24. PubMed ID: 10494830
    [Abstract] [Full Text] [Related]

  • 16. Molecular design of allergy vaccines.
    Linhart B, Valenta R.
    Curr Opin Immunol; 2005 Dec 09; 17(6):646-55. PubMed ID: 16229996
    [Abstract] [Full Text] [Related]

  • 17. Strategies for converting allergens into hypoallergenic vaccine candidates.
    Vrtala S, Focke-Tejkl M, Swoboda I, Kraft D, Valenta R.
    Methods; 2004 Mar 09; 32(3):313-20. PubMed ID: 14962766
    [Abstract] [Full Text] [Related]

  • 18. Recombinant allergens for pollen immunotherapy.
    Wallner M, Pichler U, Ferreira F.
    Immunotherapy; 2013 Dec 09; 5(12):1323-38. PubMed ID: 24283843
    [Abstract] [Full Text] [Related]

  • 19. DNA vaccines for allergy treatment.
    Weiss R, Scheiblhofer S, Thalhamer J.
    Methods Mol Med; 2006 Dec 09; 127():253-67. PubMed ID: 16988459
    [Abstract] [Full Text] [Related]

  • 20. Genetically modified allergens.
    Niederberger V, Valenta R.
    Immunol Allergy Clin North Am; 2004 Nov 09; 24(4):727-38. PubMed ID: 15474868
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.